Newsletter Subject

Daily Headlines: MSK Cancer Alliance: Mainly About Medicine

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Mon, Mar 13, 2017 11:15 AM

Email Preheader Text

Daily Headlines March 13, 2017 Additional Resources Industry Resources [Repatha? MDs: Help Get Pat

Daily Headlines March 13, 2017 [MSK Cancer Alliance: Mainly About Medicine]( [Q&A: Keeping Government from Killing Healthcare Competition]( [Digital Mammo: Better Ca Detection, But Also More Biopsies]( [More HPV Pathology with Single-Dose Vaccine]( [Few Teens Treated Well for Opioid Addiction]( Additional Resources [Diagnosis and Treatment of Relapsed Myeloma]( [AML: Beware of Pre-leukemic Clones Surviving Chemotherapy]( [Support for Omitting ALND in Early Breast Cancer]( Industry Resources [Repatha™ (evolocumab) MDs: Help Get Patients Started on Repatha™]( [Multiple Myeloma HCP Site Learn about a Treatment Option For Multiple Myeloma Relapses]( [Official Physicians' Site - ERBITUX® (cetuximab) ERBITUX® (cetuximab) View Boxed Warning, Safety & Prescribing Info]( Recent Headlines [Do You Have Imposter Syndrome?]( [House GOP's ACA Replacement Bill: What's In, What's Out?]( ['A Bad Joke': What We Heard This Week]( [Old Epilepsy Classification System Updated]( CME/CE [This Week in Zika: CV Symptoms Observed in Adults with Zika]( ADVERTISEMENT This Week's Survey [GOP Reform Bill: Better than the ACA?]( [House Republicans released their]([legislation to reform the Affordable Care Act]( -- shrinking the Medicaid program, repealing some taxes, and reshaping incentives to buy insurance -- though it left large sections of the ACA intact CME Spotlights [Skin Cancers @Point of Care]( [Source: @Point of Care]( [Are biosimilars as safe and effective as reference products?]( [Source: France Foundation]( [Playing The Offense In Advanced Basal Cell Carcinoma: A Team Approach To Treatment And Management]( [Source: RMEI Medical Education]( [Clinical Convergenceu2120: Patient and Provider Perspectives in NSCLC: Follow-up Visits]( [Source: RMEI Medical Education]( [Clinical Convergence℠: Patient and Provider Perspectives in NSCLC: Initial Visits]( [Source: RMEI Medical Education]( [A Patient-Centric, Performance Measures-Based Approach to NSCLC]( [Source: RMEI Medical Education]( [Gynecologic Cancers @Point of Care]( [Source: @Point of Care]( [Prostate Cancer @Point of Care]( [Source: @Point of Care]( [Breast Cancer @POC w/Watson]( [Source: @Point of Care]( [MDS and Acute Myeloid Leukemia (MDS and AML) @Point of Care]( [Source: @Point of Care]( More of Today's Stories [Doctors Mixed on Housecall Apps]( [PodMed: A Medical News Roundup From Johns Hopkins]( [D.C. Week: ACA Rewrite Advances After House Sleepover]( [Activity Limitations Add to Arthritis Costs]( CME/CE [Massages for Mice: That's Improbable!]( More news from MedPage Today® Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. © 2016 Medpage Today, LLC. All rights reserved. Use of this site constitutes acceptance of the [MedPageToday.com]( [terms of use]( and [privacy policy](. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Medpage Today is located at 345 Hudson Street, New York, NY 10014 [Remove me from this list](lst=Daily%20Headlines) [Manage my e-mail settings](

Marketing emails from medpagetoday.com

View More
Sent On

30/06/2024

Sent On

30/06/2024

Sent On

29/06/2024

Sent On

29/06/2024

Sent On

28/06/2024

Sent On

28/06/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2024 SimilarMail.